At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving CVVHD and/or ECMO
In Brief
A Phase 4 clinical trial evaluating pharmacokinetic blood sampling and pharmacokinetic blood and dialysate sampling for Critically Ill Renal Failure Requiring CVVHD and Oseltamivir and Critically Ill Requiring ECMO and Oseltamivir. Completed, enrolled 15 participants across 1 site.
Detailed Summary
Critically ill patients with flu may receive a drug called oseltamivir. They may also receive medical therapies to support their lung function (extracorporeal membrane oxygenation; ECMO) and kidney function (continuous venovenous hemodialysis; CVVHD). CVVHD and ECMO may remove some oseltamivir from the bloodstream. The purpose of this study is to determine how much oseltamivir gets removed by CVVHD or ECMO in critically ill patients.
Study Details
Timeline
Interventions
blood samples collected to assess oseltamivir concentrations
blood and dialysate samples collected and assayed for oseltamivir concentrations